Establishing a transcriptome-based drug discovery paradigm for neurodevelopmental disorders
Dhindsa, R. S.; Zoghbi, A. W.; Krizay, D. K.; Vasavda, C.; Goldstein, D. B.
Show abstract
Advances in genetic discoveries have created substantial opportunities for precision medicine in neurodevelopmental disorders. Many of the genes implicated in these diseases encode proteins that regulate gene expression, such as chromatin associated proteins, transcription factors, and RNA-binding proteins. The identification of targeted therapeutics for individuals carrying mutations in these genes remains a challenge, as the encoded proteins can theoretically regulate thousands of downstream targets in a considerable number of cell types. Here, we propose the application of a drug discovery approach called "transcriptome reversal" for these disorders. This approach, originally developed for cancer, attempts to identify compounds that reverse gene-expression signatures associated with disease states.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Machine Learning Identifies Novel Candidates for DrugRepurposing in Alzheimer's Disease 95%
- The Endo-GeneScreen Platform Identifies Drug-Like Probes that Regulate Endogenous Protein Levels within Physiological Contexts 95%
- NEUROeSTIMator: Using Deep Learning to Quantify Neuronal Activation from Single-Cell and Spatial Transcriptomic Data 95%
Similar papers in this journal
- A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis 94%
- ABCA7-dependent Neuropeptide-Y signalling is a resilience mechanism required for synaptic integrity in Alzheimer's disease 93%
- The genetic and phenotypic correlates of neonatal Complement Component 3 and 4 protein concentrations with a focus on psychiatric and autoimmune disorders 93%
Similar papers in this journal
- A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds 94%
- Identification of ultra-rare genetic variants in Pediatric Acute Onset Neuropsychiatric Syndrome (PANS) by exome and whole genome sequencing 93%
- Synteny: a high throughput web tool to streamline causal gene prioritisation and provide insight into protein function 93%
Similar papers in this journal
- A statistical method for image-mediated association studies discovers genes and pathways associated with four brain disorders 94%
- MIRAGE: a Bayesian rare variant association analysis method incorporating functional information of variants 94%
- Dystonia-specific mutations in THAP1 alter transcription of genes associated with neurodevelopment and myelin 93%
Similar papers in this journal
- Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson's disease 94%
- Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape 94%
- Parallel functional testing identifies enhancers active in early postnatal mouse brain 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.